What is Chematics?
Chematics, Inc. is a US-based manufacturer specializing in accessible and user-friendly diagnostic products for key health indicators such as alcohol, glucose, and cholesterol. Established in 1988, the company's product line includes the Alco-Screen and Chemcard tests, engineered for versatile application across point-of-care settings, physician offices, and home use. Chematics is dedicated to enhancing health outcomes through early detection, providing both consumers and healthcare professionals with reliable and affordable testing tools.
How much funding has Chematics raised?
Chematics has raised a total of $110K across 1 funding round:
Debt
$110K
Debt (2021): $110K with participation from PPP
What's next for Chematics?
With its recent large-scale late-stage funding, Chematics is poised for significant expansion and further product development. The major strategic investment suggests a strong market validation and confidence from backers in the company's trajectory. This capital infusion is expected to fuel advancements in manufacturing capabilities, broaden market reach for its diagnostic kits, and potentially explore new health monitoring areas. The company's focus on quality and affordability in health diagnostics positions it for sustained growth in an increasingly health-conscious global market.
See full Chematics company page
